Optina Diagnostics' Cerebral ß-Amyloid Status (CAS) Test

Clinical trial NCT05107882 · COMPLETED

Trial details

NCT number: NCT05107882
Sponsor: Optina Diagnostics Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Alzheimer Disease Mild Cognitive Impairment Mild Dementia

Start date: 2022-06-07
Primary completion: 2024-07-25
Enrollment: 466

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.